Key Highlights

  • Revenue was USD 5.78 million against an estimate of USD 5.00 million.
  • Earnings per share were USD 0.08 against an estimate of USD 0.08.
  • Net income was USD 1.53 million, compared with USD 1.82 million.
  • Cash and cash equivalents were USD 24.52 million at September 30, 2026.

ReposiTrak (NYSE:TRAK) reported Revenue of USD 5.78 million for the first quarter of fiscal 2027, which ended September 30, 2026, compared with USD 5.97 million in the prior-year quarter, against an estimate of USD 5.00 million. Basic and diluted Earnings Per Share were USD 0.08, compared with USD 0.10 basic and USD 0.09 diluted, against an estimate of USD 0.08.

Net income was USD 1.53 million, compared with USD 1.82 million. Net Income applicable to common shareholders was USD 1.50 million, compared with USD 1.76 million, after preferred stock dividends of USD 28,151.

Fiscal First Quarter Results

Cost of services and product support was USD 859,114, compared with USD 854,152. Sales and Marketing expenses were USD 1.66 million, compared with USD 1.61 million, and general and administrative expenses were USD 1.53 million, compared with USD 1.37 million. Depreciation and amortization was USD 77,426, compared with USD 243,746.

Total Operating Expense was USD 4.12 million, compared with USD 4.08 million, and income from operations was USD 1.66 million, compared with USD 1.89 million. Interest income was USD 457,968, compared with USD 363,409, and interest expense was USD 43,962, compared with USD 11,327. The company recorded a gain on remeasurement of its SPAR Investment of USD 56,959 and an unrealized loss on short-term investments of USD 51,099.

Income Taxes and Share Information

Income before income taxes was USD 2.08 million, compared with USD 2.27 million, and the provision for income taxes was USD 550,000, compared with USD 449,999. Weighted average basic shares were 18,200,000, compared with 18,288,000, and weighted average diluted shares were 18,770,000, compared with 19,130,000.

Comprehensive income was USD 1.35 million, compared with USD 1.81 million, reflecting an unrealized loss on available-for-sale securities of USD 175,861. The company had 18,201,205 common shares issued and outstanding at September 30, 2026, compared with 18,189,408 at June 30, 2026.

Balance Sheet and Liquidity

Cash and cash equivalents were USD 24,516,849 at September 30, 2026, compared with USD 27,256,008 at June 30, 2026. The company reported a current ratio of 3.98 at September 30, 2026, compared with 3.91 at June 30, 2026.

Total Assets were USD 62.99 million, compared with USD 60.86 million, and total current liabilities were USD 7.63 million, compared with USD 8.39 million. Total liabilities were USD 9.51 million, compared with USD 8.45 million. The filing also reports notes payable and finance leases as long-term liabilities.

The statement of operations reports net income applicable to common shareholders of USD 1,502,694, compared with USD 1,760,712, and dividends on preferred stock of USD 28,151, compared with USD 58,817. Total comprehensive income was USD 1,354,984, compared with USD 1,810,920. Diluted weighted average shares exceeded basic weighted average shares in both periods.

ReposiTrak Fiscal Q1 2027 Earnings: Key Takeaways

ReposiTrak reported fiscal first quarter 2027 revenue of USD 5.78 million, net income of USD 1.53 million and earnings per share of USD 0.08. Cash and cash equivalents were USD 24.52 million at September 30, 2026.